Predictive Oncology Inc. Annual Return On Equity in % from 2011 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Predictive Oncology Inc. quarterly/annual Return On Equity history and growth rate from 2011 to 2023.
  • Predictive Oncology Inc. Return On Equity for the quarter ending September 30, 2024 was -304 %, a 175% decline year-over-year.
  • Predictive Oncology Inc. annual Return On Equity for 2023 was -105 %, a 24.7% decline from 2022.
  • Predictive Oncology Inc. annual Return On Equity for 2022 was -84.3 %, a 89.5% decline from 2021.
  • Predictive Oncology Inc. annual Return On Equity for 2021 was -44.5 %, a 84.1% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -105 -20.8 -24.7% Jan 1, 2023 Dec 31, 2023
2022 -84.3 -39.8 -89.5% Jan 1, 2022 Dec 31, 2022
2021 -44.5 +236 +84.1% Jan 1, 2021 Dec 31, 2021
2020 -280 -138 -96.3% Jan 1, 2020 Dec 31, 2020
2019 -143 +203 +58.7% Jan 1, 2019 Dec 31, 2019
2018 -346 Jan 1, 2018 Dec 31, 2018
2014 192 -158 -45.1% Jan 1, 2014 Dec 31, 2014
2013 350 +73.5 +26.6% Jan 1, 2013 Dec 31, 2013
2012 276 +88.3 +47% Jan 1, 2012 Dec 31, 2012
2011 188 Jan 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.